Previous 10 | Next 10 |
It is a mixed day for cannabis names Aphria ([[APHA]] -0.6%), Aurora Cannabis ([[ACB]] +3.9%), Hexo ([[HEXO]] -0.8%), Tilray ([[TLRY]] +0.8%), Canopy Growth ([[CGC]] -1.5%), Green Thumb Industries ([[GTBIF]] +1.4%), Trulieve Cannabis ([[TCNNF]] -2.4%), Curaleaf Holdings ([[CURLF]] -2.4%) and ...
Are These Canadian Pot Stocks Worth Watching While U.S. marijuana stocks have taken all the hype in the past few months, Canadian pot stocks still have quite a bit of value. In the past few years, Canada has been the focal point of the cannabis industry. With major and minor pot...
Altria is best of breed in the world of smoke and smokeless products. This is the top of all Dividend Kings, with a 9.53% yield and 54 consecutive dividend increases in the past 50 years. All that glitters is not gold. Beware as Altria steals your capital to pay its dividend. ...
Altria Group (NYSE: MO) reported its third-quarter earnings as regular smokers seem to be holding steady, but its stake in the vape company Juul Labs and cannabis company Cronos Group (CRON) didn’t fare as well. Altria took another massive writedown on its inves...
About two years ago, Aurora Cannabis (NYSE: ACB) was considered one of the most promising marijuana companies. The pot grower was only second to Canopy Growth (NYSE: CGC) in terms of market cap at the time. Things have changed quite a bit since 2018. Canopy Growth remain...
The cannabis industry has seen its share of setbacks the past few months, and this earnings season has been the same. Will Cronos Group (CRON) be different? Read more to find out. With earnings season in full swing, we are days away from seeing how Cronos Group ( CRON ) performed ove...
While Aphria's stock price is down significantly in the past year, it has fared far better than its competitors. Overreaction to 2020 Q1 earnings provide long-term investors with attractive entry prices. On a P/S, P/B, EV/Sales, and EV/EBITDA basis, Aphria trades at a discount rel...
TORONTO, Oct. 23, 2020 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) will hold its 2020 Third Quarter Earnings Conference Call on Thursday, November 5, 2020 at 8:30 a.m. EST. Cronos Group’s senior manage...
The growing legalisation of medical cannabis is to bring total U.S. legal medical and adult-use cannabis market to $35B by 2025, according to the latest report of New Frontier Data.In the US, medical cannabis is now legal in 33 states and recreational cannabis in 10, with 5 addition...
Cronos Group (NASDAQ: CRON) and Canopy Growth (NYSE: CGC) are two highly promising cannabis companies competing in the recreational and medicinal markets worldwide. Surfing a wave of cannabis legalization in the U.S. and elsewhere, Cronos and Canopy are favorites among pure-...
News, Short Squeeze, Breakout and More Instantly...
TORONTO, July 25, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2024 second quarter earnings conference call on Thursday, August 8, 2024 at 8:30 a.m. ET. Cronos’ senior management team will discus...
TORONTO, July 22, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) announces that at its Annual Meeting of Shareholders (the “Meeting”) reconvened July 19, 2024, approximately 98.6% of shareholders voting i...